Chemoprotective action of l -(+)-selenomethionine on the modulation of genes involved in oxidative stress and in the UPR pathway

The installation of oxidative process arises from an imbalance between oxidants and antioxidants compounds, in favor of excessive generation of free radicals. This process can affect cellular components, like endoplasmic reticulum (ER). The ER is extremely sensitive to changes in homeostasis, where, on different stimuli, may result in adaptation to survival or induction of apoptosis (unfolded protein response, “UPR” pathway). The oxidative damage caused by endogenous or exogenous agents or a dysregulation of the UPR pathway can lead to adverse conditions, whose chronicity has important implications for the etiology of chronic diseases, including cancer. Therefore, it becomes important to search for chemoprotective agents aiming their role in preventive medicine. Between these substances, selenium’s antioxidant activity seems to be effective in treating diseases which have the oxidative stress as its development. We evaluated the modulating action of l-(+)-selenomethionine (SeMet) in HepG2 cells against cellular stress induced by H2O2 through MTT assay, comet assay, and gene expression by qRT-PCR of genes related to oxidative stress, UPR pathway, and apoptosis. In MTT assay, the lower concentrations of SeMet showed a cytoprotective action against the damage caused by H2O2. Likewise, it was verified in the comet assay that the concentration of 50 ng/mL reduced the genotoxic damage caused by H2O2. SeMet at 50 ng/mL regulated the genes tested in the qRT-PCR, showing an antiapoptotic and antioxidant effect. These results suggest that SeMet positively modulates the genes of oxidative stress and ER, leading to a chemoprotective and antioxidant effect, becoming an alternative in preventive medicine.